title: Drug testing in the patient: toward personalized cancer treatment.
abstract: Two different devices show that delivery of cancer drugs directly into tumors in vivo can indicate cancer sensitivity; if implemented in clinical practice, these devices have the potential to reduce indiscriminate drug use, to improve survival, and to reduce unnecessary adverse effects (Jonas et al. and Klinghoffer et al., this issue).
authors.affiliation: Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. c.coombes@imperial.ac.uk.
authors.forename: R Charles
authors.initials: RC
authors.lastname: Coombes
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000295:instrumentation*; D004354:Drug Screening Assays, Antitumor / Q000295:instrumentation* / Q000379:methods*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents